Your browser doesn't support javascript.
loading
The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.
Nolan, Claire M; Longworth, Louise; Lord, Joanne; Canavan, Jane L; Jones, Sarah E; Kon, Samantha S C; Man, William D-C.
Affiliation
  • Nolan CM; NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK Harefield Pulmonary Rehabilitation Unit, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
  • Longworth L; Health Economics Research Group, Brunel University London, London, UK.
  • Lord J; Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Southampton, UK.
  • Canavan JL; NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK.
  • Jones SE; NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK.
  • Kon SS; NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK The Hillingdon Hospitals NHS Foundation Trust, London, UK.
  • Man WD; NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK Harefield Pulmonary Rehabilitation Unit, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Thorax ; 71(6): 493-500, 2016 06.
Article in En | MEDLINE | ID: mdl-27030578
ABSTRACT

BACKGROUND:

The EQ-5D, a generic health status questionnaire that is widely used in health economic evaluation, was recently expanded to the EQ-5D-5L to address criticisms of unresponsiveness and ceiling effect.

AIMS:

To describe the validity, responsiveness and minimum important difference of the EQ-5D-5L in COPD.

METHODS:

Study 1 The validity of the EQ-5D-5L utility index and visual analogue scale (EQ-VAS) was compared with four established disease-specific health status questionnaires and other measures of disease severity in 616 stable outpatients with COPD. Study 2 The EQ-5D-5L utility index and EQ-VAS were measured in 324 patients with COPD before and after 8 weeks of pulmonary rehabilitation. Distribution and anchor-based approaches were used to estimate the minimum important difference.

RESULTS:

There were moderate-to-strong correlations between utility index and EQ-VAS with disease-specific questionnaires (Pearson's r=0.47-0.72). A ceiling effect was seen in 7% and 2.6% of utility index and EQ-VAS. Utility index decreased (worsening health status) with indices of worsening disease severity. With rehabilitation, mean (95% CI) changes in utility index and EQ-VAS were 0.065 (0.047 to 0.083) and 8.6 (6.5 to 10.7), respectively, with standardised response means of 0.39 and 0.44. The mean (range) anchor estimates of the minimum important difference for utility index and EQ-VAS were 0.051 (0.037 to 0.063) and 6.9 (6.5 to 8.0), respectively.

CONCLUSIONS:

The EQ-5D-5L is a valid and responsive measure of health status in COPD and may provide useful additional cost-effectiveness data in clinical trials.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Health Status / Surveys and Questionnaires / Pulmonary Disease, Chronic Obstructive Type of study: Qualitative_research Limits: Aged / Female / Humans / Male Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Health Status / Surveys and Questionnaires / Pulmonary Disease, Chronic Obstructive Type of study: Qualitative_research Limits: Aged / Female / Humans / Male Language: En Year: 2016 Type: Article